High EVI1 expression associates with poor survival outcome in AML. Kaplan Meier analysis of (A) overall survival (OS), (B) event-free survival (EFS), and (C) disease-free survival (DFS) shows an inferior outcome for EVI1⁺ patients in comparison with patients without EVI1 overexpression in a total cohort of 534 AML patients.